ARF6 and uveal melanoma: In line with these observations, the pharmacological blocking of ARF6 function with a small-molecule inhibitor induced an inhibitory effect on the proliferation of uveal melanoma cells and of tumorigenesis in a model of uveal melanoma, thus supporting the functional relevance of this pathway and suggesting its possible targeting at a therapeutic level [128].